-
Comment on: A Soaring Price, a Silent Fight: Thioguanine Portends New Access Barriers to Life-Saving Treatments for Children With Cancer: The Ugly Duck or The Chicken with the Golden Eggs: The Crisis in Thioguanine Accessibility
Bayoumy, A. B., Mulder, C. J. J., de Boer, N. K. H., Derijks, L. J. J., Yang, J. J. & Schmiegelow, K., Feb 2025, In: Pediatric Blood and Cancer. 72, 2, e31464.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Fecal microbiota composition is a better predictor of recurrent Clostridioides difficile infection than clinical factors in a prospective, multicentre cohort study
van Rossen, T. M., van Beurden, Y. H., Bogaards, J. A., Budding, A. E., Mulder, C. J. J. & Vandenbroucke-Grauls, C. M. J. E., Dec 2024, In: BMC infectious diseases. 24, 1, p. 687 687.Research output: Contribution to journal › Article › Academic › peer-review
-
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients
Crouwel, F., Bayoumy, A. B., Mulder, C. J. J., Peters, J. H. C., Boekema, P. J., Derijks, L. J. J., de Boer, S. Y., van de Meeberg, P. C., Ahmad, I., Buiter, H. J. C. & de Boer, N. K., 1 Sept 2024, In: Inflammatory Bowel Diseases. 30, 9, p. 1492-1499 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
